Display options
Cite
Higgins V, Piercy J, Roughley A, et al. Trends in medication use in patients with type 2 diabetes mellitus: a long-term view of real-world treatment between 2000 and 2015. Diabetes Metab Syndr Obes. 2016;9:371-380doi: 10.2147/DMSO.S120101.
Higgins, V., Piercy, J., Roughley, A., Milligan, G., Leith, A., Siddall, J., & Benford, M. (2016). Trends in medication use in patients with type 2 diabetes mellitus: a long-term view of real-world treatment between 2000 and 2015. Diabetes, metabolic syndrome and obesity : targets and therapy, 9371-380. https://doi.org/10.2147/DMSO.S120101
Higgins, Victoria, et al. "Trends in medication use in patients with type 2 diabetes mellitus: a long-term view of real-world treatment between 2000 and 2015." Diabetes, metabolic syndrome and obesity : targets and therapy vol. 9 (2016): 371-380. doi: https://doi.org/10.2147/DMSO.S120101
Higgins V, Piercy J, Roughley A, Milligan G, Leith A, Siddall J, Benford M. Trends in medication use in patients with type 2 diabetes mellitus: a long-term view of real-world treatment between 2000 and 2015. Diabetes Metab Syndr Obes. 2016 Nov 01;9:371-380. doi: 10.2147/DMSO.S120101. eCollection 2016. PMID: 27843332; PMCID: PMC5098530.
Copy Download .nbib Format: NLM
Share it on

Diabetes Metab Syndr Obes. 2016 Nov 01;9:371-380. doi: 10.2147/DMSO.S120101. eCollection 2016.

Trends in medication use in patients with type 2 diabetes mellitus: a long-term view of real-world treatment between 2000 and 2015.

Diabetes, metabolic syndrome and obesity : targets and therapy

Victoria Higgins, James Piercy, Adam Roughley, Gary Milligan, Andrea Leith, James Siddall, Mike Benford

Affiliations

  1. Adelphi Real World, Macclesfield, UK.

PMID: 27843332 PMCID: PMC5098530 DOI: 10.2147/DMSO.S120101

Abstract

BACKGROUND: Despite the availability of a variety of treatments, many patients with type 2 diabetes mellitus (T2DM) are not achieving glucose control. We analyzed successive waves of the Adelphi Real World Diabetes Disease Specific Programmes (DSPs) to assess treatment patterns reported by primary care physicians (PCPs) and specialists and the effect of treatment on levels of glucose control.

METHODS: Data were collected between 2000 and 2015 in the US and EU5 (France, Germany, Italy, Spain, and the UK). Physicians completed patient record forms for the next 10 patients consulting with T2DM. Key aspects captured were change over time in therapy usage, time to insulin introduction, and glycated hemoglobin (HbA

RESULTS: Over 12 DSP waves, 3,555 specialists and 5,109 PCPs completed questionnaires for 70,657 patients. Treatment patterns changed considerably over time as new agents were introduced. The number of agents prescribed per patient increased over time, as did HbA

CONCLUSION: In this real-world setting, the proportion of patients with T2DM achieving good glucose control has not increased greatly since 2008. A better understanding of how to individualize treatment pathways may be required to improve control in these patients.

Keywords: insulinization; real world; treatment trends; type 2 diabetes

Conflict of interest statement

The authors received no sponsorship or any outside funding or involvement in setting the research objectives, for this analysis and publication. The authors are employed by Adelphi Real World. The aut

References

  1. BMJ Open. 2016 Jan 13;6(1):e010210 - PubMed
  2. Diabetes Care. 2013 Aug;36(8):2271-9 - PubMed
  3. BMJ Open. 2016 May 04;6(5):e010210corr1 - PubMed
  4. Diabetes Obes Metab. 2012 Sep;14(9):810-20 - PubMed
  5. MMWR Suppl. 2012 Jun 15;61(2):32-7 - PubMed
  6. Diabet Med. 2013 Mar;30(3):300-8 - PubMed
  7. Curr Med Res Opin. 2008 Nov;24(11):3063-72 - PubMed
  8. Diabetologia. 2015 Mar;58(3):429-42 - PubMed

Publication Types